United Kingdom Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025
3.2 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2019
3.3 Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2019
3.4 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025
3.5 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025
3.6 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025
3.7 Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), 2019

4.1 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2015-2025
4.1.1 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
4.2 Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2025
4.2.1 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2015-2025
4.3 Glucose Monitoring Market, United Kingdom, Average Price ($) , 2015-2025
4.4 Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), 2019
4.5 Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), 2019

5.1 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2019
5.2 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019
5.3 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2025
5.3.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
5.3.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
5.4 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025
5.4.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2025
5.4.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2025
5.5 Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2025
5.6 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2019
5.7 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2019

6.1 DexCom Inc
6.1.1 Company Overview
6.2 Medtronic Plc
6.2.1 Company Overview
6.3 Abbott Laboratories
6.3.1 Company Overview
6.4 Novo Nordisk AS
6.4.1 Company Overview
6.5 Sanofi
6.5.1 Company Overview
6.6 Eli Lilly and Co
6.6.1 Company Overview
6.7 Ypsomed Holding AG
6.7.1 Company Overview
6.8 F. Hoffmann-La Roche Ltd
6.8.1 Company Overview

8.1 Equity Offerings
8.1.1 Midatech Pharma Raises USD3 Million in Private Placement of American Depositary Shares
8.1.2 Nemaura Medical to Raise up to USD19.5 Million in Public Offering of Shares
8.2 Partnerships
8.2.1 LifeScan Enters into Distribution Agreement with Sanvita Medical
8.2.2 Diabeloop and ViCentra Enter into Distribution Agreement

9.1 Corporate Communications
9.1.1 Feb 27, 2020: ConvaTec Group: Non-executive director appointment
9.1.2 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members
9.1.3 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe
9.1.4 Sep 09, 2019: Midatech Pharma announces directorate change
9.1.5 Aug 19, 2019: AstraZeneca appoints Michel Demaré to its board of directors
9.1.6 Aug 19, 2019: John McAdam appointed Chairman of ConvaTec
9.1.7 Jul 31, 2019: Midatech Pharma: Appointment of Non-Executive Director
9.1.8 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
9.1.9 Jun 25, 2019: ConvaTec Group: Board Change
9.2 Financial Announcements
9.2.1 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019
9.2.2 Feb 14, 2020: AstraZeneca: Full-year and Q4 2019 results
9.2.3 Feb 11, 2020: Nemaura Medical reports results and provides business update for the third quarter ended December 31, 2019
9.2.4 Nov 11, 2019: Nemaura medical reports results and provides business update for the second quarter ended september 30, 2019
9.2.5 Oct 24, 2019: AstraZeneca: Year-to-date and Q3 2019 results
9.2.6 Sep 30, 2019: Midatech Pharma: Interim results for the six months ended 30 June 2019
9.2.7 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report
9.2.8 Aug 09, 2019: Nemaura Medical reports quarterly results for first quarter ended June 30, 2019
9.2.9 Aug 01, 2019: ConvaTec Group first half results 2019
9.2.10 Jul 25, 2019: AstraZeneca announces H1 2019 results
9.2.11 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update
9.2.12 Apr 26, 2019: AstraZeneca: Q1 2019 results
9.2.13 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018
9.3 Government and Public Interest
9.3.1 Nov 28, 2019: Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the national reimbursement drug list in China
9.3.2 May 21, 2019: DiaMedica Therapeutics announces formation of scientific advisory board for kidney disease
9.4 Legal And Regulatory
9.4.1 Nov 12, 2019: OGT continues move into molecular diagnostics markets
9.4.2 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition
9.5 Other Significant Developments
9.5.1 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics
9.5.2 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor
9.5.3 Jul 15, 2019: EKF Diagnostics Holdings: Trading update
9.5.4 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility
9.5.5 May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business
9.6 Product News
9.6.1 Jan 13, 2020: Artificial Intelligence (AI) can detect low-glucose levels via ECG without fingerpick test
9.7 Strategy And Business Planning
9.7.1 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition
9.7.2 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
9.7.3 Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination

10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 Consulting
10.3 Contact
10.4 Disclaimer

Table 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2019
Table 3: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2015-2020
Table 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2021-2025
Table 5: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025
Table 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2015-2020
Table 7: Diabetes Care Devices Market, United Kingdom, Volume (Units), Forecast, 2021-2025
Table 8: Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019
Table 9: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 10: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 11: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 12: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 13: Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2020
Table 14: Glucose Monitoring Market, United Kingdom, Volume (Units), 2021-2025
Table 15: Blood Glucose Meters Market, United Kingdom, Volume (Units), 2015-2020
Table 16: Blood Glucose Meters Market, United Kingdom, Volume (Units), 2021-2025
Table 17: Glucose Monitoring Market, United Kingdom, Average Price ($), 2015-2020
Table 18: Glucose Monitoring Market, United Kingdom, Average Price ($), 2021-2025
Table 19: Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2019
Table 20: Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019
Table 21: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019
Table 22: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 23: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 24: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 25: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 26: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 27: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 28: Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2020
Table 29: Insulin Delivery Market, United Kingdom, Volume (Units), 2021-2025
Table 30: Insulin Pens Market, United Kingdom, Volume (Units), 2015-2020
Table 31: Insulin Pens Market, United Kingdom, Volume (Units), 2021-2025
Table 32: Insulin Pumps Market, United Kingdom, Volume (Units), 2015-2020
Table 33: Insulin Pumps Market, United Kingdom, Volume (Units), 2021-2025
Table 34: Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2020
Table 35: Insulin Delivery Market, United Kingdom, Average Price ($), 2021-2025
Table 36: Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2019
Table 37: Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019
Table 38: Diabetes Care Devices Market Pipeline Products
Table 39: Midatech Pharma Raises USD3 Million in Private Placement of American Depositary Shares
Table 40: Nemaura Medical to Raise up to USD19.5 Million in Public Offering of Shares
Table 41: LifeScan Enters into Distribution Agreement with Sanvita Medical
Table 42: Diabeloop and ViCentra Enter into Distribution Agreement

Figure 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 2: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2019
Figure 3: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2019
Figure 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2015-2025
Figure 5: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025
Figure 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2015-2025
Figure 7: Diabetes Care Devices Market, United Kingdom, Company Share (%) 2019
Figure 8: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 9: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 10: Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2025
Figure 11: Blood Glucose Meters Market, United Kingdom, Volume (Units), 2015-2025
Figure 12: Glucose Monitoring Market, United Kingdom, Company Share (%) 2019
Figure 13: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2019
Figure 14: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019
Figure 15: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 16: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 17: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 18: Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025
Figure 19: Insulin Pens Market, United Kingdom, Volume (Units), 2015-2025
Figure 20: Insulin Pumps Market, United Kingdom, Volume (Units), 2015-2025
Figure 21: Insulin Delivery Market, United Kingdom, Company Share (%) 2019 49